A detailed history of Affiance Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Affiance Financial, LLC holds 3,019 shares of ABBV stock, worth $530,076. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,019
Previous 3,019 -0.0%
Holding current value
$530,076
Previous $517,000 15.28%
% of portfolio
0.15%
Previous 0.14%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

SELL
$133.59 - $154.65 $13,091 - $15,155
-98 Reduced 3.14%
3,019 $450,000
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $5,670 - $6,800
41 Added 1.33%
3,117 $0
Q2 2022

Jul 14, 2022

SELL
$137.62 - $174.96 $110,096 - $139,968
-800 Reduced 20.64%
3,076 $471,000
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $1,187 - $1,473
-9 Reduced 0.23%
3,876 $628,000
Q2 2020

Jul 13, 2020

BUY
$73.37 - $98.18 $1,834 - $2,454
25 Added 0.65%
3,885 $381,000
Q1 2020

Apr 14, 2020

SELL
$64.5 - $97.79 $709 - $1,075
-11 Reduced 0.28%
3,860 $294,000
Q4 2019

Jan 16, 2020

SELL
$72.13 - $90.25 $14,426 - $18,050
-200 Reduced 4.91%
3,871 $343,000
Q2 2019

Jul 11, 2019

SELL
$65.7 - $83.98 $5,978 - $7,642
-91 Reduced 2.19%
4,071 $296,000
Q4 2017

Jan 16, 2018

SELL
$89.56 - $98.21 $985 - $1,080
-11 Reduced 0.26%
4,162 $403,000
Q3 2017

Dec 08, 2017

SELL
$69.85 - $89.22 $13,969 - $17,844
-200 Reduced 4.57%
4,173 $371,000
Q1 2017

Dec 08, 2017

BUY
N/A
83 Added 1.93%
4,373 $285,000
Q2 2016

Dec 08, 2017

SELL
N/A
-5 Reduced 0.12%
4,290 $266,000
Q1 2016

Dec 08, 2017

SELL
N/A
-380 Reduced 8.13%
4,295 $245,000
Q4 2015

Dec 11, 2017

SELL
N/A
-387 Reduced 7.65%
4,675 $277,000
Q3 2015

Dec 08, 2017

SELL
N/A
-87 Reduced 1.69%
5,062 $275,000
Q2 2015

Dec 08, 2017

SELL
N/A
-80 Reduced 1.53%
5,149 $346,000
Q1 2015

Dec 08, 2017

SELL
N/A
-49 Reduced 0.93%
5,229 $306,000
Q4 2014

Dec 08, 2017

BUY
N/A
5,278
5,278 $345,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Affiance Financial, LLC Portfolio

Follow Affiance Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affiance Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affiance Financial, LLC with notifications on news.